Exposure to cigarette smoke and haze (PM2.5) upregulate RFWD3 via transcription factor AhR, while inhibition of RFWD3 enhances the therapeutic efficacy of PD‐L1 blockade, providing a potential approach to tackle smohaze‐induced lung cancer. Here, RFWD3 is linked to lung cancer.